Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion
H. Bachelez, Juliet N. Barker, A. David Burden, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 10, pp. 1033-1047
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial
Akimichi Morita, Bruce Strober, A. David Burden, et al.
The Lancet (2023) Vol. 402, Iss. 10412, pp. 1541-1551
Closed Access | Times Cited: 66
Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment
R. Rivera, E. Daudén, J.M. Carrascosa, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 3, pp. 673-688
Open Access | Times Cited: 47
Current management of generalized pustular psoriasis
Nilesh Kodali, Isabella Blanchard, Sruthi Kunamneni, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 8, pp. 1204-1218
Open Access | Times Cited: 39
The role of interleukin‐36 in health and disease states
Kazumitsu Sugiura, Hideki Fujita, Mayumi Komine, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 10, pp. 1910-1925
Open Access | Times Cited: 10
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre‐specified patient subgroups in the Effisayil 1 study
A. David Burden, Yukari Okubo, Min Zheng, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 8, pp. 1279-1283
Open Access | Times Cited: 18
Genetics of Generalized Pustular Psoriasis: Current Understanding and Implications for Future Therapeutics
Syuan-Fei Yang, Min-Huei Lin, Pei-Chen Chou, et al.
Genes (2023) Vol. 14, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 18
Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis
A. David Burden
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 5, pp. 473-481
Open Access | Times Cited: 17
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study
Francesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 740-740
Open Access | Times Cited: 16
Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence
Tina Bhutani, Aaron S. Farberg
Dermatology and Therapy (2024) Vol. 14, Iss. 2, pp. 341-360
Open Access | Times Cited: 6
Spesolimab: A Review of the First IL-36 Blocker Approved for Generalized Pustular Psoriasis
Gaurav N. Pathak, Emily A. Wang, Jimmy Dhillon, et al.
Annals of Pharmacotherapy (2024)
Closed Access | Times Cited: 5
Proteomic Profiling and Clinical Insights: The Role of MMP9 in Differentiating Psoriasis Vulgaris from Generalized Pustular Psoriasis
Ting Gong, Jiawen Chen, Zhixun Xiao, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3795-3805
Open Access
Generalized Pustular Psoriasis Brazilian Experts Survey: Challenges in Disease Management
Ricardo Romiti, André Vicente Esteves de Carvalho, Cinara Prata Soares, et al.
Dermatology and Therapy (2025)
Open Access
The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab
Jason E. Hawkes, Sudha Visvanathan, James G. Krueger
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Spesolimab for generalized pustular psoriasis: a review of two key clinical trials supporting initial US regulatory approval
Eran C. Gwillim, Anna Nichols
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Global Delphi consensus on treatment goals for generalised pustular psoriasis
Juliet N. Barker, Emanuela Casanova, Siew Eng Choon, et al.
British Journal of Dermatology (2025)
Closed Access
Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis
H Schratter, Thomas Graier, Franz J. Legat, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv42177-adv42177
Open Access
Generalized pustular psoriasis: a multicentric study on patient characteristics and clinical burden
C. Bulaï Livideanu, J. Gottlieb, D. Jullien, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Epidemiology of generalized pustular psoriasis in Germany: Analyzing factors influencing prevalence estimates from claims data
Michael Schultze, Nils Kossack, Christian Kromer, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025)
Open Access
Effect of spesolimab on sustained disease control in patients with generalized pustular psoriasis: Post hoc analysis of the EFFISAYIL 2 study
Kenneth B. Gordon, Matthias Augustin, Juliet N. Barker, et al.
Journal of the American Academy of Dermatology (2025)
Open Access
Single‐cell transcriptomic analysis of GPP patients treated with IL‐12/23 or IL‐17A blockade
Soyoung Jeong, Christine Suh‐Yun Joh, Seungbok Lee, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
Safety and effectiveness of secukinumab in Japanese patients with generalized pustular psoriasis: A post‐marketing surveillance
Ayako Fujishige, Noriko Seko
The Journal of Dermatology (2025)
Open Access
Regional differences in the prevalence of generalized pustular psoriasis in Japan
Hideki Fujita, Ryoko Iwasaki, Satoshi Tsuboi, et al.
The Journal of Dermatology (2024) Vol. 51, Iss. 3, pp. 380-390
Open Access | Times Cited: 3
Epidemiology, Characteristics of Disease, and Unmet Needs of Patients with Generalized Pustular Psoriasis: A Large Italian Delphi Consensus
Francesca Prignano, Laura Atzori, Francesco Bellinato, et al.
Dermatology (2024) Vol. 240, Iss. 3, pp. 414-424
Open Access | Times Cited: 3
Health‐related quality of life in patients with generalized pustular psoriasis: A systematic literature review
Siew Eng Choon, C. Cruz, Peter Wolf, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 2, pp. 265-280
Open Access | Times Cited: 8
Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study
Monika Frysz, Smit Patel, M. Li, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 529-538
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top